Design, synthesis and biological evaluations of diverse Michael acceptor-based phenazine hybrid molecules as TrxR1 inhibitors

2021 ◽  
Vol 109 ◽  
pp. 104736
Author(s):  
Yucheng Zhong ◽  
Jing Liu ◽  
Xiangyu Cheng ◽  
Hao Zhang ◽  
Chunhua Zhang ◽  
...  
2012 ◽  
Vol 9 (2) ◽  
pp. 140-152 ◽  
Author(s):  
Romeo Romagnoli ◽  
Pier Giovanni Baraldi ◽  
Olga Cruz-Lopez ◽  
Maria Kimatrai Salvador ◽  
Delia Preti ◽  
...  

2019 ◽  
Vol 20 (6) ◽  
pp. 1300 ◽  
Author(s):  
Natalia Piekuś-Słomka ◽  
Renata Mikstacka ◽  
Joanna Ronowicz ◽  
Stanisław Sobiak

The growing interest in anticancer hybrids in the last few years has resulted in a great number of reports on hybrid design, synthesis and bioevaluation. Many novel multi-target-directed drug candidates were synthesized, and their biological activities were evaluated. For the design of anticancer hybrid compounds, the molecules of stilbenes, aromatic quinones, and heterocycles (benzimidazole, imidazole, pyrimidine, pyridine, pyrazole, quinoline, quinazoline) were applied. A distinct group of hybrids comprises the molecules built with natural compounds: Resveratrol, curcumin, coumarin, and oleanolic acid. In this review, we present the studies on bioactive hybrid molecules of a well-known tubulin polymerization inhibitor, combretastatin A-4 and its analogs with other pharmacologically active entities. The mechanism of anticancer activity of selected hybrids is discussed considering the structure-activity relationship.


2018 ◽  
Vol 145 ◽  
pp. 35-40 ◽  
Author(s):  
Wenlin Xie ◽  
Yiqiang Wu ◽  
Jingai Zhang ◽  
Qihong Mei ◽  
Yahan Zhang ◽  
...  

2018 ◽  
Vol 144 ◽  
pp. 493-503 ◽  
Author(s):  
Jiabing Wang ◽  
Di Yun ◽  
Jiali Yao ◽  
Weitao Fu ◽  
Fangyan Huang ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (38) ◽  
pp. 63187-63207 ◽  
Author(s):  
Lanlan Zang ◽  
Shukkoor M. Kondengaden ◽  
Qing Zhang ◽  
Xiaobo Li ◽  
Dilep K. Sigalapalli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document